Interaction of Clostridioides difficile infection with frailty and cognition in the elderly: a narrative review

被引:1
|
作者
Fernandez-Cotarelo, Maria-Jose [1 ]
Jackson-Akers, Jasmine Y. [2 ]
Nagy-Agren, Stephanie E. [3 ]
Warren, Cirle A. [4 ]
机构
[1] Univ Rey Juan Carlos, Hosp Univ Mostoles, Fac Hlth Sci, Dept Internal Med, Calle Doctor Luis Montes S-N, Madrid 28935, Spain
[2] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA
[3] Virginia Tech Carilion Sch Med, Salem Vet Affairs Med Ctr, Sect Infect Dis, Roanoke, VA USA
[4] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA
关键词
Clostridioides difficile infection; Aging; Microbiome; Frailty; Cognition; Gut-brain axis; RISK-FACTORS; HOSPITALIZATION INCREASES; CLINICAL CHARACTERISTICS; FUNCTIONAL STATUS; MORTALITY; OUTCOMES; DISEASE; OLDER; EPIDEMIOLOGY; IMPAIRMENT;
D O I
10.1186/s40001-023-01432-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose Clostridioides difficile infection (CDI) is the leading cause of antibiotic-related diarrhea and healthcare-associated infections, affecting in particular elderly patients and their global health. This review updates the understanding of this infection, with focus on cognitive impairment and frailty as both risk factors and consequence of CDI, summarizing recent knowledge and potential mechanisms to this interplay.Methods: A literature search was conducted including terms that would incorporate cognitive and functional impairment, aging, quality of life, morbidity and mortality with CDI, microbiome and the gut-brain axis.Results: Advanced age remains a critical risk for severe disease, recurrence, and mortality in CDI. Observational and quality of life studies show evidence of functional loss in older people after acute CDI. In turn, frailty and cognitive impairment are independent predictors of death following CDI. CDI has long-term impact in the elderly, leading to increased risk of readmissions and mortality even months after the acute event. Immune senescence and the aging microbiota are key in susceptibility to CDI, with factors including inflammation and exposure to luminal microbial products playing a role in the gut-brain axis.Conclusions: Frailty and poor health status are risk factors for CDI in the elderly. CDI affects quality of life, cognition and functionality, contributing to a decline in patient health over time and leading to early and late mortality. Narrative synthesis of the evidence suggests a framework for viewing the cycle of functional and cognitive decline in the elderly with CDI, impacting the gut-brain and gut-muscle axes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Clostridioides (Clostridium) difficile carriage in asymptomatic children since 2010: a narrative review
    Boyanova, Lyudmila
    Kalvatchev, Nikolay
    Yordanov, Daniel
    Hadzhiyski, Petyo
    Markovska, Rumyana
    Gergova, Galina
    Mitov, Ivan
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2019, 33 (01) : 1228 - 1236
  • [42] Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review
    Gilboa, Mayan
    Baharav, Nadav
    Melzer, Eyal
    Regev-Yochay, Gili
    Yahav, Dafna
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (09) : 2223 - 2240
  • [43] Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review
    Mayan Gilboa
    Nadav Baharav
    Eyal Melzer
    Gili Regev-Yochay
    Dafna Yahav
    Infectious Diseases and Therapy, 2023, 12 (9) : 2223 - 2240
  • [44] Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review
    Mihaescu, Adelina
    Augustine, Arlyn Maria
    Khokhar, Hassan Tahir
    Zafran, Mohammed
    Masood, Syed Shah Mohammed Emmad
    Gilca-Blanariu, Georgiana-Emmanuela
    Covic, Adrian
    Nistor, Ionut
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [45] Opportunities for Nanomedicine in Clostridioides difficile Infection
    Wang, Pei-Wen
    Lee, Wei-Ting
    Wu, Ya-Na
    Shieh, Dar-Bin
    ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [46] Expert Commentary on Clostridioides difficile Infection
    Stewart, David B.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (02) : 156 - 156
  • [47] Clostridioides difficile infection: an emerging zoonosis?
    Tsai, Chin-Shiang
    Hung, Yuan-Pin
    Lee, Jen-Chieh
    Syue, Ling-Shan
    Hsueh, Po-Ren
    Ko, Wen-Chien
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2021, 19 (12) : 1543 - 1552
  • [48] Ridinilazole for the treatment of Clostridioides difficile infection
    Carlson, Travis J.
    Endres, Bradley T.
    Basseres, Eugenie
    Gonzales-Luna, Anne J.
    Garey, Kevin W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (04) : 303 - 310
  • [49] Clostridioides (Clostridium) difficile Pacemaker Infection
    Berkefeld, Anna
    Berger, Fabian K.
    Gartner, Barbara C.
    Wantia, Nina
    Prinzing, Anatol
    Laugwitz, Karl-Ludwig
    Busch, Dirk H.
    Rothe, Kathrin
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (12):
  • [50] Update on Treatment of Clostridioides difficile Infection
    Cho, Janice M.
    Pardi, Darrell S.
    Khanna, Sahil
    MAYO CLINIC PROCEEDINGS, 2020, 95 (04) : 758 - 769